⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aminoserine SCHEMBL277836 | 1.00 | — | — | |
| Aminoserine SCHEMBL277837 | 1.00 | — | — | |
| Aminoserine SCHEMBL853082 | 0.97 | — | — | |
| Aminoserine SCHEMBL853081 | 0.97 | — | — | |
| Aminoserine SCHEMBL5114875 | 0.97 | — | — | |
| Aminoserine SCHEMBL8506214 | 0.94 | — | — | |
| Aminoserine SCHEMBL15668067 | 0.94 | SLC1A1 (0.37) | — | |
| Aminoserine SCHEMBL8506211 | 0.94 | — | — | |
| Aminoserine SCHEMBL3166789 | 0.89 | SLC1A1 (0.34) | — | |
| Aminoserine SCHEMBL17491742 | 0.89 | LMNA (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118787626-A | Application of D-serine compound in preparation of neuromodulator and brain dysfunction treatment drug | 宁波大学 | 2024-10-18 | — | — | CN | claimed |
| CN-112135830-B | Oxo-substituted compounds | 住友制药株式会社 | 2024-06-14 | — | — | CN | claimed |
| CN-111533708-A | Preparation method of chiral N-tert-butoxycarbonylmorpholine-3-carboxylic acid | 上海馨远医药科技有限公司 | 2020-08-14 | — | — | CN | claimed |
| US-12324839-B2 | Testosterone-inducing peptide compounds and associated combinations | ACESIS BIOMED US, INC. (US) | 2025-06-10 | — | — | US | disclosed |
| CN-117720619-B | Polypeptide, anti-photoaging polypeptide and application of polypeptide | 杭州禾泰健宇生物科技有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-118787626-A | Application of D-serine compound in preparation of neuromodulator and brain dysfunction treatment drug | 宁波大学 | 2024-10-18 | — | — | CN | disclosed |
| CN-118787626-A | Application of D-serine compound in preparation of neuromodulator and brain dysfunction treatment drug | 宁波大学 | 2024-10-18 | — | — | CN | disclosed |
| US-12116343-B2 | Inhibitors of APOL1 and methods of using same | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2024-10-15 | — | — | US | disclosed |
| CN-118638140-A | Oxo-substituted compounds | 住友制药株式会社 | 2024-09-13 | — | — | CN | disclosed |
| CN-112135830-B | Oxo-substituted compounds | 住友制药株式会社 | 2024-06-14 | — | — | CN | disclosed |
| WO-2024100139-A1 | USE OF IFN-I ACTIVITY AS A BIOMARKER FOR TLR INHIBITOR TREATMENT | MERCK PATENT GMBH (DE) | 2024-05-16 | — | — | WO | disclosed |
| EP-0359399-A1 | Process for the enzymatic production of dipeptides | CARLBIOTECH LTD. A/S (DK) | 1990-03-21 | — | — | EP | disclosed |
| WO-1990001555-A1 | A PROCESS FOR ENZYMATIC PRODUCTION OF DIPEPTIDES OR STRUCTURALLY RELATED COMPOUNDS | CARLBIOTECH LTD. A/S (DK) | 1990-02-22 | — | — | WO | disclosed |
| US-4870190-A | INTERMEDIATES FOR ARTIFICIAL SWEETENERS | PFIZER INC. (US) | 1989-09-26 | — | — | US | disclosed |
| US-4797298-A | ARTIFICIAL SWEETENERS FOR BEVERAGES | PFIZER, INC. (US) | 1989-01-10 | — | — | US | disclosed |
| US-4517379-A | ARTIFICIAL SWEETENER | PFIZER INC. (US) | 1985-05-14 | — | — | US | disclosed |
| EP-0069811-B1 | BRANCHED AMIDES OF L-ASPARTYL-D-AMINO ACID DIPEPTIDES AND COMPOSITIONS THEREOF | PFIZER INC. (US) | 1984-10-24 | — | — | EP | disclosed |
| US-4454328-A | SWEETENERS | PFIZER INC. (US) | 1984-06-12 | — | — | US | disclosed |
| US-4399163-A | ARTIFICIAL SWEETENERS | PFIZER INC. (US) | 1983-08-16 | — | — | US | disclosed |
| EP-0069811-A1 | Branched amides of L-aspartyl-D-amino acid dipeptides and compositions thereof | PFIZER INC. (US) | 1983-01-19 | — | — | EP | disclosed |